Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NTRA Natera Inc
- Stocks
- Healthcare
- NASDAQ: NTRA
Price (delayed)
$162.57
Market cap
$21.98B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.53
Enterprise value
$21.21B
Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a
Highlights
Natera's gross profit has surged by 108% YoY and by 16% QoQ
The company's debt has shrunk by 62% QoQ and by 59% YoY
The quick ratio has declined by 9% since the previous quarter
Key stats
What are the main financial stats of NTRA
Market
Valuations
Earnings
Shares outstanding
135.19M
Market cap
$21.98B
Enterprise value
$21.21B
Price to earnings (P/E)
N/A
Price to book (P/B)
17.95
Price to sales (P/S)
11.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.5
Revenue
$1.7B
Gross profit
$1.02B
Operating income
-$222.29M
Net income
-$190.43M
EBIT
-$179.05M
EBITDA
-$132.75M
Free cash flow
$69.24M
Per share
Balance sheet
Liquidity
EPS
-$1.53
EPS diluted
-$1.53
Free cash flow per share
$0.56
Book value per share
$9.05
Revenue per share
$13.61
TBVPS
$13.32
Total assets
$1.66B
Total liabilities
$465.32M
Debt
$176.95M
Equity
$1.2B
Working capital
$1.03B
Debt to equity
0.15
Current ratio
4
Quick ratio
3.73
Net debt/EBITDA
5.79
Margins
Efficiency
Dividend
EBITDA margin
-7.8%
Gross margin
60.3%
Net margin
-11.2%
Operating margin
-13.1%
Return on assets
-12.2%
Return on equity
-20.6%
Return on invested capital
-23.7%
Return on capital employed
-13.6%
Return on sales
-10.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NTRA stock price
How has the Natera stock price performed over time
Intraday
1.54%
1 week
7.41%
1 month
22.94%
1 year
69.95%
YTD
2.7%
QTD
14.96%
Financial performance
How have Natera's revenue and profit performed over time
Revenue
$1.7B
Gross profit
$1.02B
Operating income
-$222.29M
Net income
-$190.43M
Gross margin
60.3%
Net margin
-11.2%
Natera's gross profit has surged by 108% YoY and by 16% QoQ
The company's net margin has surged by 72% YoY and by 20% QoQ
NTRA's operating margin has surged by 68% year-on-year and by 17% since the previous quarter
NTRA's revenue has surged by 57% year-on-year and by 11% since the previous quarter
Price vs fundamentals
How does NTRA's price correlate with its fundamentals
Growth
What is Natera's growth rate over time
Valuation
What is Natera stock price valuation
P/E
N/A
P/B
17.95
P/S
11.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.5
The EPS has soared by 60% YoY and by 13% from the previous quarter
NTRA's equity has surged by 56% year-on-year and by 36% since the previous quarter
The stock's P/B is 32% more than its 5-year quarterly average of 13.6 and 10% more than its last 4 quarters average of 16.3
NTRA's revenue has surged by 57% year-on-year and by 11% since the previous quarter
NTRA's price to sales (P/S) is 17% higher than its last 4 quarters average of 10.2 and 11% higher than its 5-year quarterly average of 10.8
Efficiency
How efficient is Natera business performance
The ROS has soared by 73% YoY and by 18% from the previous quarter
The ROE has soared by 67% YoY and by 21% from the previous quarter
The ROA has soared by 62% year-on-year and by 15% since the previous quarter
The return on invested capital has increased by 45% year-on-year
Dividends
What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NTRA.
Financial health
How did Natera financials performed over time
NTRA's total liabilities is down by 35% since the previous quarter and by 31% year-on-year
NTRA's total assets is up by 15% YoY and by 4.4% QoQ
The company's debt is 85% lower than its equity
The debt to equity has plunged by 73% YoY and by 72% from the previous quarter
The company's debt has shrunk by 62% QoQ and by 59% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.